Early-onset neuroinflammation drives neurodegeneration caused by lysosomal PI(3,5)P2 insufficiency

Bridget Wong1, Morgan Payne2, Alexander Silva3

  • 1Department of Pathology, University of California San Diego, San Diego, CA 92093, USA.

Insights

Phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2] deficiency causes fatal neurological diseases. Early neuroinflammation, including microglial activation and cell death pathways, precedes neurodegeneration, implicating lysosomal dysfunction in brain development and disease.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2] is a critical lysosomal lipid.
  • Deficiency in PI(3,5)P2, due to mutations in PIKfyve complex genes (e.g., Fig. 4, VAC14), underlies severe neurological disorders like Charcot-Marie-Tooth type 4J (CMT4J) and amyotrophic lateral sclerosis (ALS).
  • Understanding the brain's molecular response to PI(3,5)P2 insufficiency is crucial for deciphering these diseases.

Purpose of the Study:

  • To comprehensively map the molecular consequences of PI(3,5)P2 insufficiency in the brain.
  • To investigate the role of lysosomal function in neurodevelopment and neuroinflammation.
  • To identify key molecular players and pathways involved in PI(3,5)P2-deficiency-driven neurodegeneration.

Main Methods:

  • Quantitative proteomic and transcriptomic analyses were performed on three mouse models with loss-of-function mutations in Fig. 4 or Vac14.
  • Brain tissues were examined at both presymptomatic (postnatal day 5) and end stages.
  • Isolated microglia were analyzed for their transcriptional state and reactive oxygen species production.

Main Results:

  • Profound neuroinflammation, characterized by complement activation, interferon signaling, and myeloid/T-cell infiltration, was evident by postnatal day 5, preceding significant neurodegeneration.
  • Mutant microglia displayed a pro-oxidative transcriptional state, indicating a non-cell-autonomous phenotype.
  • PI(3,5)P2 insufficiency disrupted the normal developmental remodeling of the brain proteome, with key proteins failing to accumulate during postnatal maturation.
  • Multifactorial inflammatory cell death pathways (apoptosis, pyroptosis, necroptosis) were activated, involving elevated levels of p53, Fas receptor, inflammatory caspases, Gasdermin D, RIPK1, and ZBP1.
  • Dysregulated proteins were linked to genes implicated in lysosomal storage disorders and neurodegenerative diseases (ALS, CMT, Alzheimer's, Parkinson's).

Conclusions:

  • Early-onset neuroinflammation is a defining and likely initiating feature of neurodegeneration caused by lysosomal PI(3,5)P2 disruption.
  • Lysosomal function is critical for proper neurodevelopment and brain proteome maturation.
  • The findings highlight the broad pathogenic relevance of PI(3,5)P2 insufficiency across a spectrum of neurological and lysosomal storage disorders.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...